Biorem Inc (BRM.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 473 | 383 | 351 | 344 | 354 |
| Income taxes - deferred | 383 | 459 | 84 | 382 | 506 |
| Accounts receivable | 239 | -3,038 | -1,723 | -2,528 | -2,534 |
| Accounts payable and accrued liabilities | -2,516 | 1,381 | 744 | 3,251 | -26 |
| Other Working Capital | -441 | -2,742 | -736 | 1,700 | 322 |
| Other Operating Activity | 5,546 | 4,048 | 2,726 | 632 | 4,712 |
| Operating Cash Flow | $3,685 | $490 | $1,445 | $3,782 | $3,335 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -372 | -553 | -203 | -76 | -342 |
| Investing Cash Flow | $-372 | $-553 | $-203 | $-76 | $-342 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | -775 | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | N/A | 5,010 | N/A |
| Debt Repayment | -729 | -623 | -954 | -239 | -200 |
| Common Stock Issued | 157 | 69 | N/A | N/A | N/A |
| Common Stock Repurchased | N/A | N/A | 0 | -12,411 | N/A |
| Other Financing Activity | 0 | 0 | 2 | 85 | 0 |
| Financing Cash Flow | $-572 | $-1,329 | $-952 | $-7,556 | $-200 |
| Exchange Rate Effect | 180 | -91 | -986 | -548 | -393 |
| Beginning Cash Position | 2,292 | 3,775 | 4,471 | 8,869 | 6,469 |
| End Cash Position | 5,213 | 2,292 | 3,775 | 4,471 | 8,869 |
| Net Cash Flow | $2,741 | $-1,392 | $290 | $-3,850 | $2,793 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,685 | 490 | 1,445 | 3,782 | 3,335 |
| Capital Expenditure | -372 | -553 | -203 | -76 | -342 |
| Free Cash Flow | 3,313 | -63 | 1,242 | 3,706 | 2,993 |